High Point Advisor Group LLC Brainstorm Cell Therapeutics Inc. Transaction History

High Point Advisor Group LLC

  • $1.75 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
BUY
$3.01 - $4.01 $3,010 - $4,010
1,000 Added 6.24%
17,033 $65,000
Q1 2021

Apr 12, 2021
BUY
$3.46 - $7.88 $1,038 - $2,364
300 Added 1.91%
16,033 $59,000
Q4 2020

Feb 10, 2021
BUY
$3.99 - $17.73 $8,778 - $39,006
2,200 Added 16.26%
15,733 $115,000
Q1 2020

May 01, 2020
BUY
$4.01 - $8.88 $53,938 - $119,444
13,451 Added 16403.66%
13,533 $82,000
Q1 2020

Apr 27, 2020
BUY
$4.01 - $8.88 $328 - $728
82 New
82 $13.5 Million

Others Institutions Holding BCLI

# of Institutions
9
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $56.9M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email